201 - Simplifying HCV Diagnosis and Treatment

Saturday, October 19, 2024

10:30 AM – 11:45 AM US PT

Location: 515 A

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Michael Melia, MD (he/him/his)

ID Fellowship Program Director
Johns Hopkins University
Baltimore, MD, United States
Rachel Baden, MD (she/her/hers)

Chief of Medicine
Los Angeles General Medical Center
Pasadena, CA, United States

Faculty(s)

AA

Andrew Aronsohn
Carolyn Wester, MD, MPH (she/her/hers)

Director, Division of Viral Hepatitis
Centers for Disease Control and Prevention
Jennifer Price, MD, PhD

Professor of Medicine
Department of Medicine
University of California, San Francisco
San Francisco, CA, United States

Disclosure(s):

Michael T. Melia, MD: No financial relationships to disclose

Rachel Baden, MD: No financial relationships to disclose

Andrew Aronsohn: No financial relationships to disclose

Carolyn Wester, MD, MPH: No financial relationships to disclose

Jennifer C. Price, MD, PhD: AbbVie Inc: Grant/Research Support (Ongoing); Gilead Biosciences: Grant/Research Support (Terminated, May 7, 2024); Vir Biotechnology: Grant/Research Support (Ongoing)

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe ways in which point-of-care hcv diagnostics have the potential to decentralize hcv testing and treatment;
investigate ways in which you can incorporate simplified hcv treatment into your practice;
describe the potential impact integrating point-of-care hcv diagnostics into existing high-impact programs might have on hcv elimination efforts.

Presentations:

10:30 AM – 10:55 AM US PT

New HCV diagnostics & decentralization of HCV testing and treatment
Speaker: Carolyn Wester, MD, MPH (she/her/hers) – Centers for Disease Control and Prevention
10:55 AM – 11:20 AM US PT

Further simplification of HCV treatment
Speaker: Andrew Aronsohn
11:20 AM – 11:45 AM US PT

Integrating POC HCV RNA testing into mobile, syringe services, opioid treatment, and other high-impact programs
Speaker: Jennifer C. Price, MD, PhD – University of California, San Francisco